Capital Group Private Client Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Capital Group Private Client Services's ABBV Position: Q2 2026 in Review
Capital Group Private Client Services reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $1.29M and leaving 51,628 shares worth $13M. The position accounts for 0.18% of the portfolio, ranked #54.
Capital Group Private Client Services first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $94M in Q3 2024. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Capital Group Private Client Services held 51,628 shares of AbbVie worth $13M as of Q2 2026.
- Capital Group Private Client Services sold 6,018 AbbVie shares in Q2 2026, an estimated $1.29M.
- AbbVie made up 0.18% of Capital Group Private Client Services's portfolio in Q2 2026, its #54 holding.
- Capital Group Private Client Services first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- Capital Group Private Client Services's AbbVie position peaked at $94M in Q3 2024.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Capital Group Private Client Services's 13F filing for Q2 2026, filed 12 Aug 2026.